HomeCompareKMGIF vs MRK

KMGIF vs MRK: Dividend Comparison 2026

KMGIF yields 6.95% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMGIF wins by $42902.36M in total portfolio value
10 years
KMGIF
KMGIF
● Live price
6.95%
Share price
$17.97
Annual div
$1.25
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42902.42M
Annual income
$41,749,065,773.43
Full KMGIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KMGIF vs MRK

📍 KMGIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKMGIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KMGIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KMGIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KMGIF
Annual income on $10K today (after 15% tax)
$591.07/yr
After 10yr DRIP, annual income (after tax)
$35,486,705,907.42/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KMGIF beats the other by $35,486,697,579.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KMGIF + MRK for your $10,000?

KMGIF: 50%MRK: 50%
100% MRK50/50100% KMGIF
Portfolio after 10yr
$21451.24M
Annual income
$20,874,537,785.79/yr
Blended yield
97.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KMGIF
No analyst data
Altman Z
3.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KMGIF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKMGIFMRK
Forward yield6.95%2.76%
Annual dividend / share$1.25$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$42902.42M$56.8K
Annual income after 10y$41,749,065,773.43$9,798.13
Total dividends collected$42823.15M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KMGIF vs MRK ($10,000, DRIP)

YearKMGIF PortfolioKMGIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,091$1,390.76$11,206$366.19+$885.00KMGIF
2$16,080$3,143.06$12,650$502.35+$3.4KKMGIF
3$25,019$7,813.33$14,407$694.19+$10.6KKMGIF
4$49,493$22,722.89$16,585$967.82+$32.9KKMGIF
5$136,978$84,020.38$19,342$1,363.89+$117.6KKMGIF
6$581,213$434,646.01$22,913$1,947.19+$558.3KKMGIF
7$4,069,089$3,447,191.31$27,662$2,823.89+$4.04MKMGIF
8$49,464,010$45,110,085.06$34,159$4,173.35+$49.43MKMGIF
9$1,077,898,493$1,024,972,002.03$43,337$6,308.80+$1077.86MKMGIF
10$42,902,417,161$41,749,065,773.43$56,776$9,798.13+$42902.36MKMGIF

KMGIF vs MRK: Complete Analysis 2026

KMGIFStock

Kamigumi Co., Ltd. provides an integrated logistics services in Japan and internationally. The company offers harbor transportation services; warehousing storage and distribution processing services; and truck, air, and rail transportation services, as well as sea freight services. It also provides on-site factory services, including loading and unloading of ship-borne raw materials; transportation of materials to sites; and provision of secondary processing, product controls/shipping work, and environmental response work services. In addition, the company offers heavy cargo transportation services for transformer plants, industrial equipment, petrochemical plant equipment, and railcars. Further, it provides construction services for housing, warehouses, offices, and stores; offers breakdown and disposal services for large equipment and facilities, such as steel plant rolling mill production lines and large conveyor systems for sand and rock; designs and constructs steel structures; constructs and maintains amusement facilities; and provides machinery maintenance services. Additionally, the company engages in apartment rental; alcoholic beverage production; and restaurant businesses, as well as solar business. It also develops and leases commercial facilities, operates parking areas, and cultivates tomatoes. Kamigumi Co., Ltd. was founded in 1867 and is headquartered in Kobe, Japan.

Full KMGIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KMGIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KMGIF vs SCHDKMGIF vs JEPIKMGIF vs OKMGIF vs KOKMGIF vs MAINKMGIF vs JNJKMGIF vs ABBVKMGIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.